This material is educational and describes substances as research-use reagents. It is not medical advice and not a usage instruction for humans.
Ozempic has become a household name, but behind the one brand is a molecule, semaglutide, and a whole family of similar drugs. Below is a calm, no-hype scientific breakdown: what semaglutide is, how it works, how Ozempic differs from Wegovy, Rybelsus and Mounjaro, what "analogues" mean, and, most important in a market full of fakes, how to tell real semaglutide from a fake by its lab certificate (COA).
What Ozempic and semaglutide are
Ozempic is a brand name whose active substance is semaglutide. Semaglutide belongs to the class of GLP-1 receptor agonists, molecules that mimic the natural GLP-1 hormone the gut releases after eating.
GLP-1 is an incretin hormone: it boosts glucose-dependent insulin release, slows gastric emptying and acts on satiety centres in the brain. Semaglutide reproduces this action but lasts markedly longer than natural GLP-1.
How semaglutide works
- Satiety. Acting on appetite centres reduces hunger.
- Slower gastric emptying. Food stays in the stomach longer, satiety comes sooner.
- Glycaemic control. Glucose-dependent insulin release and glucagon suppression.
The "less appetite + longer fullness" combination is what drives the effect on body weight. Clinical research on semaglutide (the STEP and SUSTAIN programmes) studied its effect on body weight and cardiovascular markers, the detailed, source-cited breakdown lives in our monographs.
Ozempic, Wegovy, Rybelsus, Mounjaro, the difference
| Name | Molecule | Targets | Format |
|---|---|---|---|
| Ozempic | semaglutide | GLP-1 | injection |
| Wegovy | semaglutide (higher dose) | GLP-1 | injection |
| Rybelsus | semaglutide | GLP-1 | tablets |
| Mounjaro | tirzepatide | GIP + GLP-1 | injection |
| Saxenda | liraglutide | GLP-1 | injection |
| No approved brand (RUO) | retatrutide | GIP + GLP-1 + glucagon | investigational |
Ozempic and Wegovy are the same molecule (semaglutide), but they are separate registered products with their own approved indications, dosing and dosage forms. Under the current FDA labeling Wegovy comes both as an injection and as tablets. Rybelsus is oral semaglutide. Mounjaro is already a different molecule, tirzepatide, acting on two receptors at once. Saxenda is an older drug built on liraglutide, also GLP-1, but with a shorter duration of action. Retatrutide is a research molecule hitting three targets at once, still with no approved brand.
Frequently asked questions
- Are Ozempic and semaglutide the same thing? No. Semaglutide is the active substance. Ozempic is the brand name of one registered product built on it.
- How does Wegovy differ from Ozempic? Same molecule, different products: each has its own approved indications, dosing and dosage forms.
- Is Mounjaro an analogue of Ozempic? Only in everyday speech. It is a different molecule, tirzepatide, acting on two receptors instead of one.
- What should you check in a COA? The batch number, the laboratory, the analysis date and three separate things: identity, purity and quantity.
- What does RUO mean? Research use only, material for laboratory research. It carries no medical labeling and is not intended for administration to humans or animals.
Ozempic, Wegovy, Rybelsus, Mounjaro and Saxenda are registered trademarks of their respective manufacturers (Novo Nordisk and Eli Lilly). Longeva is not their affiliated distributor and does not sell these branded drugs, the comparison above is purely to explain the brand-versus-molecule difference.
Analogues of Ozempic: from brand swaps to research-use semaglutide
When people search for "Ozempic analogues," they usually mean one of two things:
- Other branded drugs: Wegovy and Rybelsus (both are semaglutide, just in a different form), Mounjaro (tirzepatide), and the older liraglutide sold as Saxenda. The pharmacy route for each of them means a prescription, a price and periodic shortages, and each of these molecules has a research-use counterpart in the Longeva lineup.
- Research-use semaglutide, the same molecule as a research reagent (full profile on the semaglutide wiki page), without the brand markup, but also without pharmacy quality guarantees. And here everything comes down to one question: how is purity proven?
In the second case the market drowns in fakes: relabeled Chinese powder, underdosed vials, Telegram sellers who vanish. You can't tell real from fake by eye, you need a document.
How to tell real semaglutide from a fake: COA and batch verification
- COA (Certificate of Analysis), a lab certificate for a specific batch: the substance's identity and its purity percentage by a third-party assay. No COA, no conversation.
- Identity, purity and quantity are three different things. An HPLC purity figure tells you what fraction of the peptide in the sample is the target one, but it neither confirms the substance itself nor shows how many milligrams are in the vial. That is why an underdosed vial is not caught by a clean purity report: it needs a separate quantitative assay.
- Batch verification. A good supplier lets you verify a specific lot, not show one certificate "for everything." At longeva, batches ship with a COA, the open certificate archive is public, and a lot can be opened at
/verify/{lot}. - Red flags: no COA; one certificate for all batches; a seller only in a messenger with no public verification; a price far below market "for the same purity."
The rule is simple: verifiable purity over price. A cheap fake is wasted money and a ruined experiment, not a saving.
Price and availability in Ukraine
Branded Ozempic at the pharmacy means a prescription, a high price and periodic shortages. Research-use semaglutide is more affordable, but shifts all responsibility for quality onto the buyer, which is why a COA and batch verification stop being a "nice bonus" and become a requirement.
